Healthtech startup Vial laid off its entire site network division in October 2022, affecting 40 to 50 employees, which represented about 32-40% of its then 125-person workforce. These cuts, part of multiple rounds of layoffs that year, came as a surprise to staff, especially since the company announced a $67 million Series B funding round just weeks later. The layoffs resulted from a strategic shift away from managing clinical trial divisions at clinics to focusing on its software offerings. Founded in 2020, Vial operates in the healthtech industry, helping biotech companies run clinical trials.
